ORPHAN DRUGS IN FRANCE: KEY MARKET ACCESS INCENTIVES

被引：0
|
作者：
Mennezein, L. [1 ]
Avot, D. [1 ]
Laigle, V [2 ]
机构：
[1] MSD France, Courbevoie, France
[2] MSD Vaccins, Lyon, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.943
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY116
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [41] MARKET ACCESS, PRICING AND REIMBURSEMENT PROCESSES FOR ORPHAN DRUGS IN THE EU-5 COUNTRIES: A COMPARATIVE ASSESSMENT
    Vollmer, L.
    Prada, M.
    Benazet, F.
    Berard, I
    Lopez, N.
    Guterres, S.
    Walzer, S.
    VALUE IN HEALTH, 2019, 22 : S854 - S854
  • [42] PRICING AND MARKET ACCESS OF ORPHAN DRUGS IN CHINA: ANALYSIS OF NATIONAL AND PROVINCIAL POLICY AND THE ASSOCIATED IMPACT ON COVERAGE
    Sherwin, G.
    Akpinar, P.
    Yap, B.
    VALUE IN HEALTH, 2016, 19 (07) : A835 - A835
  • [43] Determinants of orphan drugs prices in France: a regression analysis
    Korchagina, Daria
    Millier, Aurelie
    Vataire, Anne-Lise
    Aballea, Samuel
    Falissard, Bruno
    Toumi, Mondher
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [44] Orphan drugs, incentives and uncertainty about their risk-benefit balance
    Leache, Leire
    Saiz, Luis Carlos
    Gutierrez-Valencia, Marta
    Erviti, Juan
    GACETA SANITARIA, 2021, 35 (02) : 208 - 209
  • [45] ECONOMIC IMPACT OF THE END OF THE MARKET EXCLUSIVITY FOR ORPHAN DRUGS
    Kandel, M.
    Degrassat-Theas, A.
    de Curzon, Parent O.
    Sinegre, M.
    Paubel, P.
    VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [46] Access to orphan drugs in Europe: current and future issues
    Michel, Morgane
    Toumi, Mondher
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (01) : 23 - 29
  • [47] IS THERE AN IMPACT OF THE ORPHAN DESIGNATION IN ONCOLOGY ON MARKET ACCESS IN EUROPE?
    Boiziau, S. C.
    VALUE IN HEALTH, 2015, 18 (03) : A220 - A220
  • [48] ORPHAN DRUGS, START-UPS, AND MARKET SIZES
    不详
    BIO-TECHNOLOGY, 1987, 5 (11): : 1108 - 1109
  • [49] ACCESS TO ORPHAN DRUGS IN GREECE DURING ECONOMIC CRISIS
    Tsiantou, V
    Mylona, K.
    Karampli, E.
    Boubouchairopoulou, N.
    Kyriopoulos, I. I.
    Athanasakis, K.
    Gabriel, E.
    Makridaki, D.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2014, 17 (07) : A541 - A541
  • [50] Access to orphan drugs - comparison across Balkan countries
    Pejcic, Ana V.
    Iskrov, Georgi
    Jakovljevic, Mihajlo Michael
    Stefanov, Rumen
    HEALTH POLICY, 2018, 122 (06) : 583 - 589
12345